251 related articles for article (PubMed ID: 33178973)
1. Glioma surveillance imaging: current strategies, shortcomings, challenges and outlook.
Abdalla G; Hammam A; Anjari M; D'Arco DF; Bisdas DS
BJR Open; 2020; 2(1):20200009. PubMed ID: 33178973
[TBL] [Abstract][Full Text] [Related]
2. MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.
Aquino D; Gioppo A; Finocchiaro G; Bruzzone MG; Cuccarini V
J Immunol Res; 2017; 2017():5813951. PubMed ID: 28512646
[TBL] [Abstract][Full Text] [Related]
3. Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.
Jaspan T; Morgan PS; Warmuth-Metz M; Sanchez Aliaga E; Warren D; Calmon R; Grill J; Hargrave D; Garcia J; Zahlmann G
AJNR Am J Neuroradiol; 2016 Sep; 37(9):1581-7. PubMed ID: 27127006
[TBL] [Abstract][Full Text] [Related]
4. Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors.
Overcast WB; Davis KM; Ho CY; Hutchins GD; Green MA; Graner BD; Veronesi MC
Curr Oncol Rep; 2021 Feb; 23(3):34. PubMed ID: 33599882
[TBL] [Abstract][Full Text] [Related]
5. Response Assessment in Neuro-Oncology Criteria for Gliomas: Practical Approach Using Conventional and Advanced Techniques.
Leao DJ; Craig PG; Godoy LF; Leite CC; Policeni B
AJNR Am J Neuroradiol; 2020 Jan; 41(1):10-20. PubMed ID: 31857322
[TBL] [Abstract][Full Text] [Related]
6. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
[TBL] [Abstract][Full Text] [Related]
7. A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults.
Ellingson BM; Sanvito F; Cloughesy TF; Huang RY; Villanueva-Meyer JE; Pope WB; Barboriak DP; Shankar LK; Smits M; Kaufmann TJ; Boxerman JL; Weller M; Galanis E; Groot J; Gilbert MR; Lassman AB; Shiroishi MS; Nabavizadeh A; Mehta M; Stupp R; Wick W; Reardon DA; Vogelbaum MA; van den Bent M; Chang SM; Wen PY
AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38926092
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma.
Youssef G; Rahman R; Bay C; Wang W; Lim-Fat MJ; Arnaout O; Bi WL; Cagney DN; Chang YS; Cloughesy TF; DeSalvo M; Ellingson BM; Flood TF; Gerstner ER; Gonzalez Castro LN; Guenette JP; Kim AE; Lee EQ; McFaline-Figueroa JR; Potter CA; Reardon DA; Huang RY; Wen PY
J Clin Oncol; 2023 Jun; 41(17):3160-3171. PubMed ID: 37027809
[TBL] [Abstract][Full Text] [Related]
9. RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
Wen PY; van den Bent M; Youssef G; Cloughesy TF; Ellingson BM; Weller M; Galanis E; Barboriak DP; de Groot J; Gilbert MR; Huang R; Lassman AB; Mehta M; Molinaro AM; Preusser M; Rahman R; Shankar LK; Stupp R; Villanueva-Meyer JE; Wick W; Macdonald DR; Reardon DA; Vogelbaum MA; Chang SM
J Clin Oncol; 2023 Nov; 41(33):5187-5199. PubMed ID: 37774317
[TBL] [Abstract][Full Text] [Related]
10. Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Erker C; Tamrazi B; Poussaint TY; Mueller S; Mata-Mbemba D; Franceschi E; Brandes AA; Rao A; Haworth KB; Wen PY; Goldman S; Vezina G; MacDonald TJ; Dunkel IJ; Morgan PS; Jaspan T; Prados MD; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e317-e329. PubMed ID: 32502458
[TBL] [Abstract][Full Text] [Related]
11. Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Fangusaro J; Witt O; Hernáiz Driever P; Bag AK; de Blank P; Kadom N; Kilburn L; Lober RM; Robison NJ; Fisher MJ; Packer RJ; Young Poussaint T; Papusha L; Avula S; Brandes AA; Bouffet E; Bowers D; Artemov A; Chintagumpala M; Zurakowski D; van den Bent M; Bison B; Yeom KW; Taal W; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e305-e316. PubMed ID: 32502457
[TBL] [Abstract][Full Text] [Related]
12. A Comparative Retrospective Study of Immunotherapy RANO
Chen X; Lim-Fat MJ; Qin L; Li A; Bryant A; Bay CP; Gao L; Miskin N; Liu Z; Iorgulescu JB; Xu X; Reardon DA; Young GS
Front Oncol; 2021; 11():679331. PubMed ID: 34249718
[TBL] [Abstract][Full Text] [Related]
13. Response Assessment in Neuro-Oncology Criteria and Clinical Endpoints.
Huang RY; Wen PY
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):705-718. PubMed ID: 27742111
[TBL] [Abstract][Full Text] [Related]
14. [Pseudoprogression or pseudoresponse: a challenge for the diagnostic imaging in Glioblastoma multiforme].
Payer F
Wien Med Wochenschr; 2011 Jan; 161(1-2):13-9. PubMed ID: 21312094
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
16. Advanced MRI Techniques in the Monitoring of Treatment of Gliomas.
Hyare H; Thust S; Rees J
Curr Treat Options Neurol; 2017 Mar; 19(3):11. PubMed ID: 28349351
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis.
Abbasi AW; Westerlaan HE; Holtman GA; Aden KM; van Laar PJ; van der Hoorn A
Clin Neuroradiol; 2018 Sep; 28(3):401-411. PubMed ID: 28466127
[TBL] [Abstract][Full Text] [Related]
18. High-grade glioma management and response assessment-recent advances and current challenges.
Khan MN; Sharma AM; Pitz M; Loewen SK; Quon H; Poulin A; Essig M
Curr Oncol; 2016 Aug; 23(4):e383-91. PubMed ID: 27536188
[TBL] [Abstract][Full Text] [Related]
19. Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.
Huang RY; Neagu MR; Reardon DA; Wen PY
Front Neurol; 2015; 6():33. PubMed ID: 25755649
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Brain Tumor Response: RANO and Its Offspring.
Eisele SC; Wen PY; Lee EQ
Curr Treat Options Oncol; 2016 Jul; 17(7):35. PubMed ID: 27262709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
